The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Prev Story
Next Story
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
1 reads
0 reactions
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Tags:
This story is currently in the Upcoming News queue because it received more dislikes than likes. Vote thumbs up to help promote it back to the Published homepage!
Browse Upcoming Feed
Related Stories
Technology
The Age
•
5h ago
#attalah
The Guardian view on press freedom: authoritarians target journalism because it matters | Editorial
The Guardian
•
5h ago
TechCrunch
•
10m ago
SBS News Australia
•
2h ago
1 / 1